CLINICAL_TRIALS
withdrawal
· 2016-10-31
Clinical Trial Update: 99m-Technetium- Glucosamine in Arthritis
Summary
A clinical trial evaluating 99m-Technetium-Glucosamine for rheumatoid arthritis and ankylosing spondylitis is no longer available, indicating the study has been…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Sydney | Conditions: Rheumatoid Arthritis, Ankylosing Spondylitis | Status: NO_LONGER_AVAILABLE